Nomura Holdings, Inc.
NYSE:NMRFinancial - Capital Markets
-$0.12 today
- Market cap
- $27.29B
- Beta
- 0.61
- P/E (TTM)
- 0.3
- EPS (TTM)
- $4,986.67
- Dividend yield
- 3.55%
Volume 3.51M
Average 1.75M
NMR Depreciation & Amortization
Non-cash expense that spreads the cost of physical and intangible assets over their useful lives.
Nomura Holdings, Inc.NYSE: NMR
Depreciation & Amortization · Q1 FY2027 · quarter ended Jun 2026
Depreciation & amortization remains negative
Q1 FY2027 depreciation & amortization was ¥0, compared with ¥0 a year earlier. Trailing-twelve-month depreciation & amortization was ¥19.39B. Over 3 fiscal years it compounded at +3.6% a year.
Context
- Depreciation & amortization amounted to 1.4% of revenue in FY2026, unchanged from a year earlier.
- Depreciation & amortization increased in 2 of the last 3 fiscal years.
- FY2026 was the highest annual figure in the 4 fiscal years shown.
What to watch
Whether quarterly depreciation & amortization holds near ¥0 or moves back toward the trailing-twelve-month quarterly average of ¥4.85B.
Sources:Income StatementText generated from reported figures; not investment advice.
Depreciation & Amortization history
JPY · from the income statement
- Latest · FY2026
- 68.27B JPY
- Year-over-year change
- +10.7%
- 4-year CAGR
- +3.5%
| Period | Period end | Depreciation & Amortization | YoY change |
|---|---|---|---|
| FY2026 | 2026-03-31 | 68.27B | +10.7% |
| FY2025 | 2025-03-31 | 61.65B | +0.5% |
| FY2024 | 2024-03-31 | 61.34B | -0.1% |
| FY2023 | 2023-03-31 | 61.42B | +3.2% |
| FY2022 | 2022-03-31 | 59.52B | — |
Depreciation & Amortization vs competitors
How NMR compares with its peers on the latest reported figures
- Peers report in different currencies, so depreciation & amortization is compared through growth and share of revenue rather than absolute size.
- Depreciation & amortization amounts to 0.4% of revenue for NMR, versus a peer median of 1.9%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Jun 2026 | ¥19.39B JPY | — | +3.6% | 0.4% | |
| LTM Jun 2026 | $3.28B USD | -12.7% | +19.6% | 4.3% | |
| LTM Sep 2026 | $3.05B USD | -40.9% | +5.2% | 2.4% | |
| LTM Sep 2026 | $2.07B USD | -3.9% | -3.9% | 1.7% | |
| LTM Aug 2026 | $189.42M USD | -5.6% | +2.2% | 1.5% | |
| LTM Sep 2026 | $136.31M USD | +64.0% | +10.7% | 2.0% | |
| LTM Mar 2026 | $37.85M USD | +1.3% | +3.1% | 2.2% | |
| LTM Jun 2026 | $26.87M USD | +208.7% | -28.4% | 0.6% | |
| LTM Sep 2026 | $23.82M USD | -30.7% | -30.8% | 0.7% | |
| Peer median (excluding NMR) | — | -4.8% | +2.6% | 1.9% | |
Competitors are the stored peer set for NMR. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2022 Mar 2022 | FY2023 Mar 2023 | FY2024 Mar 2024 | FY2025 Mar 2025 | FY2026 Mar 2026 |
|---|---|---|---|---|---|
| Revenue | 1.37T | 2.3T | 3.97T | 4.51T | 4.76T |
| Cost of Revenue | 230.11B | 1.15T | 2.6T | 2.84T | 2.59T |
| Gross Profit | 1.14T | 1.14T | 1.38T | 1.66T | 2.17T |
| Gross Margin | 83.3% | 49.9% | 34.7% | 36.9% | 45.6% |
| Research & Development | 0 | 0 | 0 | 0 | 0 |
| Selling, General & Admin | 529.51B | 605.79B | 673.52B | 732.39B | 1.37T |
| Operating Expenses | 917.09B | 995.5B | 1.1T | 1.19T | 1.63T |
| Depreciation & Amortization | 59.52B | 61.42B | 61.34B | 61.65B | 68.27B |
| EBITDA | 286.15B | 210.9B | 335.19B | 533.62B | 608.09B |
| EBITDA Margin | 20.8% | 9.2% | 8.4% | 11.8% | 12.8% |
| Operating Income | 226.62B | 149.47B | 273.85B | 471.96B | 539.82B |
| Operating Margin | 16.5% | 6.5% | 6.9% | 10.5% | 11.3% |
| Interest Income | 284.22B | 1.11T | 2.62T | 2.93T | 2.67T |
| Interest Expense | 230.11B | 1.15T | 2.6T | 2.84T | 2.59T |
| Other Income / Expenses | 0 | 0 | 0 | 0 | 0 |
| Income Before Tax | 226.62B | 149.47B | 273.85B | 471.96B | 539.82B |
| Pre-Tax Margin | 16.5% | 6.5% | 6.9% | 10.5% | 11.3% |
| Income Tax Expense | 80.09B | 57.8B | 96.63B | 124.71B | 165.44B |
| Net Income | 143B | 92.79B | 165.86B | 340.74B | 362.13B |
| Net Margin | 10.4% | 4.0% | 4.2% | 7.6% | 7.6% |
| EPS (Basic) | 46.68 | 30.86 | 54.97 | 115.30 | 123.08 |
| EPS (Diluted) | 45.23 | 29.74 | 52.75 | 111.03 | 118.99 |
| Weighted Avg Shares | 3.06B | 3.01B | 3.02B | 2.96B | 2.94B |
| Weighted Avg Shares (Diluted) | 3.16B | 3.11B | 3.14B | 3.07B | 3.04B |
Nomura Holdings, Inc.
NYSE:NMR
Intrinsic Alpha fair value
Locked
Current Price
$9.23
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.